
Hosts Mitsuaki Sawano, MD, and Shun Kohsaka, MD, welcome Kazuma Ohyama, MD, PhD (Tohoku University) to discuss the BRIDGE trial, Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome. In this 10-center cluster-randomized trial, hospitals were assigned to either protocol-based or standard lipid management after emergency PCI for ACS. Rather than simply reminding clinicians to intensify therapy, the intervention specified what treatment to initiate, when to reassess LDL-C, when to escalate therapy, and who was responsible for each step. At 6 months, LDL-C
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Is “Normal” Hemoglobin Really Normal in Heart Failure? | JACC Baran

ESC 2026 Special: JACC SimPub Papers You Should Know | JACC Baran

The Lancet: OPTIMA-AF, Is 1 Month Enough After PCI? | JACC Baran

HFpEF: Why Earlier May Be Better | JACC Baran
Free AI-powered recaps of JACC Global and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.